This interactive symposium will focus on translating research to innovation to commercial offering and linking it with career progression from researcher to innovator to business leadership. Women from leadership roles in successfully commercializing science will share key factors for success during an interactive panel, followed by a moderated Q&A where members can get questions answered and where responses will be summarized and made available post meeting.
THE SYMPOSIUM INVITES ALL TO EXPLORE WITH US:
- WHAT does it take to be an INNOVATING WOMAN in business and industry?
- WHAT are their key traits for success?
- HOW have they built support structures and connections throughout their careers?
- WHAT role do both women and men play in expanding the role of INNOVATING WOMEN across the chemical enterprise?
- ....and most importantly HOW can you use this information to create your own INNOVATOR PATHWAY TO SUCCESS?
Bonnie Fendrock, Co-founder and CEO at Cyta Therapeutics, Inc.
Bernadette “Bonnie” C. Fendrock is a life science entrepreneur and executive. Currently, she is the CEO and Co-founder of Cyta Therapeutics, a spin-out from UMass, Amherst. Cyta is developing targeted nanotherapeutics based on the novel polymer chemistry of Dr. S. “Thai” Thayumanavan. Cyta’s X-actogels are a nanogel technology with a wide range of clinical applications; ovarian cancer is an area of initial focus.Prior to Cyta, Ms. Fendrock was co-founder and CEO of Hepregen Corporation, a venture backed, commercial stage, MIT technology spin-out.
Ms. Fendrock is a member of Golden Seeds, is a Director, Executive Women Series, for the Boston Chapter of the Healthcare Businesswomen’s Association (HBA) and has been a mentor for many entrepreneurs.
She has a BA in Molecular Biology from Wellesley College, an SM in Interdisciplinary Science from MIT, and an MBA from The Wharton School, University of Pennsylvania.
Dawn Mason, Manager, Portfolio and Special Projects at Eastman Chemical Company; Chair, ACS Corporation Associates
Dawn Mason is currently a Portfolio and Special Projects Manager at Eastman Chemical Company, where she keeps watch on a multimillion-dollar technology portfolio. She has held a number of managerial positions and successfully led a variety of technology groups contributing in areas from catalysis to polymer modification and from technical service to process improvement. She is the chair for the ACS Committee on Corporation Associates and is a member of the ACS Leadership Advisory Board.
She has a Ph.D. from Texas A&M University in Chemistry, and a BS in Chemistry from the University of Missouri – Columbia.
MARTA PIÑEIRO-NÚÑEZ, DIRECTOR, OPEN INNOVATION DRUG DISCOVERY, ELI LILLY AND COMPANY
Marta Piñeiro-Núñez is the Director of Open Innovation Drug Discovery (OIDD) at Eli Lilly and Company, an American global pharmaceutical company headquartered in Indianapolis, Indiana. She has been with Eli Lilly since 1997, starting as a medicinal chemist in cognition, cardiovascular disease and psychosis projects and lead generation. In 2009 Marta launched the initial open innovation program and website at Eli Lilly and was awarded the Lilly Research Labs President’s Award; in 2012 she was named the Director of the OIDD. Marta has served as the President of the Organization of Latinos at Lilly since 2014.
She has a PhD in Organic Chemistry from Indiana University, and a BS in Chemistry from University of Santiago de Compostela in Spain.
Marcia Stone, Co-Founder & Managing Partner at GGS Venture Partners; Golden Seeds
Dr. Marcia Stone is a scientist, inventor and entrepreneur. She is the Co-founder and Managing Member of GGS Venture Partners, a venture firm that invests in companies and cutting-edge consumer products that solve problems and improve people’s lives, and is part of both Golden Seeds and Boston Harbor Angels.
Dr. Stone was the Founder, President and CEO of Hybrivet Systems, Inc., where her focus was on utilizing chemical methodology, monoclonal antibody technology and methods of biotechnology as the basis for diagnostic products. Dr. Stone manufactured Hybrivet’s flagship product, LeadCheck®, which detected lead contamination.
She has an PhD in Organic Chemistry from Northeastern University.
Janet Bryant, Systems & Science Policy Analyst/project manager at the Pacific Northwest National Laboratory
▸ SYMPOSIUM Organizer
Janet is a Systems & Science Policy Analyst and project manager at the Pacific Northwest National Laboratory, where she has been innovating for over 30 years. She uses her knowledge of human capital and organizational development to deliver Lens of the Market training.
Janet chairs the American Chemical Society (ACS) Chemical Innovation and Entrepreneurship Council (CIEC). She received the prestigious Federal Laboratory Consortium’s Excellence in Technology Transfer Award for successful commercialization, and has been elected an ACS Fellow and ACS Richland Section “Chemist of the Year” for 2013.
Judy Giordan, Managing Director of ecosVC®, professor of practice at Oregon state university
▸ Symposium Organizer and Symposium Moderator
Co-founder of the Chemical Angels Network, entrepreneur and former Fortune 100 executive, Judy serves as board member, co-founder, advisor and investor in seed and early stage start-ups.
Her previous executive positions include Vice President and Global Corporate Director of Research and Development at International Flavors and Fragrances, Inc.; Vice-President Worldwide Research and Development for the Pepsi-Cola Company, the global beverage arm of PepsiCo, Inc.; Vice President Research and Development, Henkel Corporation, the North American operating unit of the Henkel Group; and co-founder and managing partner of 1EXECStreet, a successful San Francisco based boutique executive search firm. She has also held management and technical contributor positions at Polaroid and ALCOA and has served with the National Science Foundation as Program Director for the IGERT Program.